University of California San Francisco

Peter Kouretas MD Phd
Peter Kouretas, MD, PhD

Professor of Surgery
Division of Pediatric Cardiothoracic Surgery
Surgical Director, Pediatric Heart Transplantation

Address

550 16th Street, #5603
San Francisco, CA 94158
United States

    Biography

    Peter C. Kouretas, MD, PhD, is Professor of Surgery in the UCSF Department of Surgery and surgical director of the Pediatric Heart Transplantation.

    Dr. Kouretas earned his MD, PhD at Georgetown University in Washington, DC. After a surgical internship at UC Irvine, he completed his general surgery residency at the University of Virginia. Dr. Kouretas then completed his cardiothoracic surgical residency at the University of Pennsylvania, also serving as Chief Resident in Pediatric Heart Surgery at the Children’s Hospital of Philadelphia. Dr. Kouretas then went on to a clinical fellowship in pediatric and congenital heart surgery as well as pediatric heart transplantation at Stanford University. 

    Prior to joining the faculty at UCSF, Dr. Kouretas was the chief of pediatric cardiothoracic surgery and co-director of the pediatric heart center at Rainbow Babies & Children’s Hospital. Dr. Kouretas’ background also includes serving as the director of the pediatric mechanical circulatory program at Primary Children’s Medical Center at the University of Utah. 

    Dr. Kouretas’ clinical and research interests focus on pediatric heart transplantation and mechanical circulatory support.  The use of cardiac devices as a bridge to transplantation as well as recovery is a focus of the pediatric heart failure program at UCSF Benioff Children’s Hospital. 

    The continuity of care of adults with congenital heart disease is also a focus of the Pediatric Heart Program at UCSF Benioff Children’s Hospitals.  Dr. Kouretas has a special interest in aortic disease in this population, particularly valve sparing aortic root procedures in the Marfan population. 

    Dr. Kouretas is a member of numerous professional societies, including the Society of Thoracic Surgeons, The Western Thoracic Surgical Association, and the International Society for Heart and Lung Transplantation.  Dr. Kouretas has published extensively and is actively involved in multiple clinical and research protocols.

    Education

    Institution Degree Dept or School End Date
    University of California Diversity, Equity, and Inclusion Champion Training 2019

    Board Certifications

    American Board of Thoracic Surgery, Thoracic and Cardiac Surgery
    American Board of Thoracic Surgery, Congenital Cardiac Surgery

    Clinical Expertise

    Arterial Switch

    Atrial Fibrillation

    Atrial Septal Defect

    Atrioventricular Heart Block

    Heart Transplantation

    Heart Valve Disease

    Hypoplastic Left Heart Syndrome

    Marfan Syndrome

    Mitral Valve Repair & Replacement

    Myocardial Revascularization Surgery

    Norwood Procedure

    Patent Ductus Arteriosus

    Pediatric Heart Failure

    Pediatric/Adult Congenital Heart Surgery

    Tetralogy of Fallot

    Transposition of Great Arteries

    Ventricular Aneurysm

    Ventricular Assist Devices (VAD)

    Ventricular Septal Defect

    In the News

    July, 17, 2018 | UCSF Division of Pediatric Cardiothoracic Surgery

    Publications

    MOST RECENT PUBLICATIONS FROM A TOTAL OF 48
    1. Non-anticoagulant heparin increases endothelial nitric oxide synthase activity: role of inhibitory guanine nucleotide proteins.
      Kouretas PC, Hannan RL, Kapur NK, Hendrickson R, Redmond EM, Myers AK, Kim YD, Cahill PA, Sitzmann JV| | PubMed
    2. Heparin preserves nitric oxide activity in coronary endothelium during ischemia-reperfusion injury.
      Kouretas PC, Kim YD, Cahill PA, Myers AK, To LN, Wang YN, Wallace RB, Kron IL, Hannan RL| | PubMed
    3. 17-Beta estradiol regulation of myocardial glutathione and its role in protection against myocardial stunning in dogs.
      Kim YD, Farhat MY, Myers AK, Kouretas P, DeGroot KW, Pacquing A, Ramwell PW, Suyderhoud JP, Lees DE| | PubMed
    4. Early discharge of patients with new-onset atrial fibrillation after cardiovascular surgery.
      Solomon AJ, Kouretas PC, Hopkins RA, Katz NM, Wallace RB, Hannan RL| | PubMed
    5. Heparin and nonanticoagulant heparin preserve regional myocardial contractility after ischemia-reperfusion injury: role of nitric oxide.
      Kouretas PC, Myers AK, Kim YD, Cahill PA, Myers JL, Wang YN, Sitzmann JV, Wallace RB, Hannan RL| | PubMed
    6. Maturation alters the pulmonary arterial response to hypoxia and inhaled nitric oxide in the presence of endothelial dysfunction.
      Myers JL, Wizorek JJ, Myers AK, O'Donoghue M, Pettit MT, Kouretas PC, Dalton HJ, Wang Y, Hopkins RA| | PubMed
    7. 17 beta-Estradiol prevents dysfunction of canine coronary endothelium and myocardium and reperfusion arrhythmias after brief ischemia/reperfusion.
      Kim YD, Chen B, Beauregard J, Kouretas P, Thomas G, Farhat MY, Myers AK, Lees DE| | PubMed
    8. Pulmonary arterial endothelial dysfunction potentiates hypercapnic vasoconstriction and alters the response to inhaled nitric oxide.
      Myers JL, Wizorek JJ, Myers AK, Yankah E, Pettit MT, Kouretas PC, Dalton HJ, Wang Y, Hopkins RA| | PubMed